Campuses

As France's leading biocluster, Genopole is an incubator for cutting-edge projects in biotechnology. Located in the city of Évry, just south of Paris, Genopole provides a unique environment for scientists and entrepreneurs seeking to advance research and innovation.

Discover >

Advantages

Genopole accompanies researchers, postdocs and start-up entrepreneurs through all the phases of their projects to ensure the best possible conditions for business development.

Discover >

Genopole’s citizens

Every day, at Genopole, researchers, entrepreneurs and students cross paths, share ideas and unite forces in a veritable melting pot for innovation.

Discover >

Highlights

Giving wings to research and empowering employment in our community are cornerstones of Genopole's mission. Catch up on recent scientific advances, the accomplishments of our biotech actors and the events that enliven the biocluster.

Discover >

Innovate with us

Discover >
Company

FABMID


4, rue Pierre Fontaine – Genopole Campus 3
91058 EVRY-COURCOURONNES Cedex – FRANCE

Pichugin Andrey: CEO & CSO
Web Site >
FABMID - entreprise génopolitaine FABMID - entreprise génopolitaine

Shaker#Industrial Biotech

  • Cell therapy
  • Gene therapy
  • non-viral vectorBooster
  • transfection
  • CAR-T cells
  • bioproduction

Field of Activity


We develop a cutting-edge DNA vector to reduce the cost and improve efficiency of cell and gene therapy

BACKGROUND
Andrey Pichugin, PhD and former leader of a public research lab, is a molecular genetics specialist. He has been developing Fabmid’s technology since early 2019 and has founded the startup in 2020.

DESCRIPTION OF THE PRODUCTS / SERVICES / TECHNOLOGY

To improve cell and gene therapy, our DNA vector is both easy to produce in small or large quantities and has all the advantageous properties for a vector: compared to other viral and non-viral vectors, it has high cell transfection efficiency, low toxicity or immunogenicity, high selectivity and high stability. It can be used for transient or stable transfection. As a result, it helps reduce the cost and length of gene therapy R&D programs, as well as manufacturing costs

COLLABORATIONS SOUGHT

  • Biopharma developing cell or gene therapy
  • Researcher experimenting in the field of oncology, immunology, virology…

 

  • Futher informations

    1 Patent

    Strengths
    A cutting-edge technology for numerous applications, a very large market and a complementary team

    InnovationAssets:
    A robust technology with singular qualities, highly valuable for research and scalable for industrial production

Share
Genopole’s Companies

#Industrial Biotech


In same field

Proteinea - Genopole's company

Proteinea

Production as a service (PaaS) platform capable of producing recombinant proteins & enzymes cheaper and on a scale.

Discover
Altar - entreprise génopolitaine

Altar

Altar is a specialist in the conception and operation of automated fluidic continuous culture systems for adaptive laboratory evolution and the development of microbial strains for industry.

Discover
Yposkesi - Genopole's Company

Yposkesi

YposKesi is the first French company to develop and manufacture gene and cell therapy products for rare diseases.

Discover
Watchfrog Laboratory - Genopole's company

WatchFrog

WatchFrog markets in vivo biotechnological solutions for environmental risk assessment and the evaluation of the therapeutic, toxic or pollutant potential of all types of chemical, cosmetic or pharmaceutical compounds.

Discover
Pymabs - Genopole's Company

Pymabs

R & D services in the field of transient expression of recombinant proteins in plants.

Discover
Pharming - Genopole's company - Logo 2021

PHARMING

Pharming specializes in the production of recombinant proteins in transgenic rabbit milk.

Discover
Glowee - Genopole's company

Glowee

Glowee is a cleantech startup developing a disruptive lighting technology based on bioluminescence (the natural light-producing property of certain living organisms).

Discover
Global Bioenergies - Genopole's company

Global Bioenergies

Global Bioenergies is developing a process to convert renewable resources into hydrocarbons through fermentation.

Discover
ABOLIS - entreprise génopolitaine

Abolis Biotechnologies

Development of custom-order microorganisms able to produce molecules of interest in health, nutrition, cosmetics, chemistry and agriculture.

Discover
View all >
With support